Skip to main content

Market Overview

UPDATE: UBS Investment Research Lowers PT on CME Group Following Solid 2Q Results

Share:

In a report published Friday, UBS Investment Research analyst Alex Kramm reiterated a Buy rating on CME Group (NASDAQ: CME), but lowered the price target from $84.00 to $83.00.

In the report, UBS Investment Research noted, “Despite solid 2Q results CME declined some 3% today. We believe investors were overly focused on slightly higher expense guidance, lower OTC clearing fee capture, energy pricing incentives, and a sharp slowdown in July volumes (from elevated levels). Given the significant run in the shares in May/June, we are not surprised to see the stock take some pause. That said, we believe the current weakness provides a nice set-up into the fall, when debate about monetary policy should increase again and new growth initiatives play out further.”

CME Group closed on Thursday at $72.17.

Latest Ratings for CME

DateFirmActionFromTo
Mar 2022RosenblattMaintainsNeutral
Mar 2022UBSMaintainsBuy
Mar 2022Credit SuisseMaintainsNeutral

View More Analyst Ratings for CME

View the Latest Analyst Ratings

 

Related Articles (CME)

View Comments and Join the Discussion!

Posted-In: Alex Kramm UBS Investment ResearchAnalyst Color Price Target Analyst Ratings

Latest Ratings

StockFirmActionPT
SEDGB of A SecuritiesMaintains411.0
PTLOPiper SandlerMaintains28.0
AOUTLake StreetMaintains26.0
RAPTPiper SandlerMaintains52.0
OCXLake StreetMaintains6.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com